☰

Global Genome Editing/Genome Engineering Market

Report ID : 1174 | Published : 2022-02-28 | Pages: 140 | Format: PDF/EXCEL

Share

Genome engineering is the technique that involves gene modification by certain process include DNA is insertion, cutting, modification or replacement of genome of a living organism. Due to increasing the research and development spend by companies and organization fueling the highest growth of genome engineering market.

Advancement in genomic technologies helping research organizations to take deep dive in genome engineering hence companies are making significant investment in Research and development. For instance, Thermo Fisher Scientific is developing cutting edge CRISPR technology for providing better efficiency and accuracy in research, and to fulfil the unmet demands in research and therapeutics. Additionally, contribution by the research organization and universities are tremendous creating high impact in the market. For instance, in November 2015, a new CRISPR technology was developed by scientists at the University of Massachusetts Medical School. This technology help in the genome editing at specific target location.

The Global Genome Editing/Genome Engineering market is segmented on the basis of base technology, product, application, end users and region. Based on the base type, the market is divided into CRISPR, TALEN, ZFN, antisense and other technologies. On the basis of product, the market is segmented into reagents & consumables, software & systems and services. Based on the application, the market is divided into animal genetic engineering, plant genetic engineering, diagnostic applications, drug discovery & development and other. Based on the end users, the market is divided into pharmaceutical companies, biotechnology companies, academic & government and research institutes. Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among that Europe held the largest share of the market, followed by America and Asia Pacific. On the other hand, North America is expected to dominate the market during the analysis of forecast period.

The key players of this market include Thermo Fisher Scientific Inc., Merck & Co. Inc, Horizon Discovery group plc, Genscript biotech corporation, Sangamo Therapeutics Inc., lonza group ltd, Editas Medicine Inc, Crispr Therapeutics, Eurofins Scientific Inc, Precision Biosciences Inc, Oxford Genetics Ltd., Intellia Therapeutics Inc, Synthego corporation, Vigene Biosciences Inc, Epigenie, Integrated DNA Technologies Inc, New England Biolabs Inc, Origene Technologies Inc, Transposagen Biopharmaceuticals Inc, Creative Biogene Inc  among others.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Genome Editing/Genome Engineering Market Snapshot

Chapter 4. Global Genome Editing/Genome Engineering Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Industry Analysis – Porter’s Five Forces Analysis

4.6. Competitive Landscape & Market Share Analysis

4.7. Major Investment, Partnerships and Collaborations in Genomics Research

Chapter 5. Market Segmentation 1: By Technology Estimates & Trend Analysis

5.1. By Technology & Market Share, 2020 & 2028

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2028 for the following By Technology:

5.2.1. CRISPR

5.2.2. TALEN

5.2.3. ZFN

5.2.4. Antisense

5.2.5. Other Technologies

Chapter 6. Market Segmentation 1: Product Estimates & Trend Analysis

6.1. Product Type & Market Share, 2020 & 2028

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2028 for the following Product Type:

6.2.1. Reagents & Consumables

6.2.2. Software & Systems

6.2.3. Services

Chapter 7. Market Segmentation 1: Application Estimates & Trend Analysis

7.1. Application Type & Market Share, 2020& 2028

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2028 for the following Application Type:

7.2.1. Animal Genetic Engineering

7.2.2. Plant Genetic Engineering

7.2.3. Diagnostic Applications

7.2.4. Drug Discovery & Development

7.2.5. Other

Chapter 8. Market Segmentation 2: End-Users Estimates & Trend Analysis

8.1. End-Users & Market Share, 2020 & 2028

8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2028 for the following End-Users:

8.2.1. Pharmaceutical Companies

8.2.2. Biotechnology Companies

8.2.3. Academic & Government Research Institutes

Chapter 9. Genome Editing/Genome Engineering Market Segmentation 3: Regional Estimates & Trend Analysis

9.1. North America

9.1.1. North America Genome Editing/Genome Engineering Market revenue (US$ Million) estimates and forecasts by By Technology, 2020-2028

9.1.2. North America Genome Editing/Genome Engineering Market revenue (US$ Million) estimates and forecasts by Product, 2020-2028

9.1.3. North America Genome Editing/Genome Engineering Market revenue (US$ Million) estimates and forecasts by Application, 2020-2028

9.1.4. North America Genome Editing/Genome Engineering Market revenue (US$ Million) estimates and forecasts by End-Users, 2020-2028

9.1.5. North America Genome Editing/Genome Engineering Market revenue (US$ Million) estimates and forecasts by country, 2020-2028

9.2. Europe

9.2.1. Europe Genome Editing/Genome Engineering Market revenue (US$ Million) by By Technology, 2020-2028

9.2.2. Europe Genome Editing/Genome Engineering Market revenue (US$ Million) by Product, 2020-2028

9.2.3. Europe Genome Editing/Genome Engineering Market revenue (US$ Million) by Application, 2020-2028

9.2.4. Europe Genome Editing/Genome Engineering Market revenue (US$ Million) by End-Users, 2020-2028

9.2.5. Europe Genome Editing/Genome Engineering Market revenue (US$ Million) by country, 2020-2028

9.3. Asia Pacific

9.3.1. Asia Pacific Genome Editing/Genome Engineering Market revenue (US$ Million) by By Technology, 2020-2028

9.3.2. Asia Pacific Genome Editing/Genome Engineering Market revenue (US$ Million) by Product, 2020-2028

9.3.3. Asia Pacific Genome Editing/Genome Engineering Market revenue (US$ Million) by Application, 2020-2028

9.3.4. Asia Pacific Genome Editing/Genome Engineering Market revenue (US$ Million) by End-Users, 2020-2028

9.3.5. Asia Pacific Genome Editing/Genome Engineering Market revenue (US$ Million) by country, 2020-2028

9.4. Latin America

9.4.1. Latin America Genome Editing/Genome Engineering Market revenue (US$ Million) by By Technology, (US$ Million)

9.4.2. Latin America Genome Editing/Genome Engineering Market revenue (US$ Million) by Product, (US$ Million)

9.4.3. Latin America Genome Editing/Genome Engineering Market revenue (US$ Million) by Application, (US$ Million)

9.4.4. Latin America Genome Editing/Genome Engineering Market revenue (US$ Million) by country, (US$ Million) 2020-2028

9.5. Middle East & Africa

9.5.1. Middle East & Africa Genome Editing/Genome Engineering Market revenue (US$ Million) by By Technology, (US$ Million)

9.5.2. Middle East & Africa Genome Editing/Genome Engineering Market revenue (US$ Million) by Product, (US$ Million)

9.5.3. Middle East & Africa Genome Editing/Genome Engineering Market revenue (US$ Million) by Application, (US$ Million)

9.5.4. Middle East & Africa Genome Editing/Genome Engineering Market revenue (US$ Million) by country, (US$ Million) 2020-2028 

Chapter 10. Competitive Landscape

10.1. Major Mergers and Acquisitions/Strategic Alliances

10.2. Company Profiles

10.2.1. Thermo Fisher Scientific Inc.

10.2.2. Merck & Co. Inc

10.2.3. Horizon Discovery group plc

10.2.4. Genscript biotech corporation

10.2.5. Sangamo Therapeutics Inc.

10.2.6. lonza group ltd

10.2.7. Editas Medicine Inc

10.2.8. Crispr Therapeutics

10.2.9. Eurofins Scientific Inc

10.2.10. Precision Biosciences Inc

10.2.11. Oxford Genetics Ltd.

10.2.12. Intellia Therapeutics Inc

10.2.13. Synthego corporation

10.2.14. Vigene Biosciences Inc

10.2.15. Epigenie

10.2.16. Integrated DNA Technologies Inc

10.2.17. New England Biolabs Inc

10.2.18. Origene Technologies Inc

10.2.19. Transposagen Biopharmaceuticals Inc

10.2.20. Creative Biogene Inc

10.2.21. Other Prominent Player

Global Genome Editing/Genome Engineering Market Segmentation:

Global Genome Editing/Genome Engineering Market Revenue (US$ Mn) by Technology

  • CRISPR
  • TALEN
  • ZFN
  • Antisense
  • Other Technologies

Global Genome Editing/Genome Engineering Market Revenue (US$ Mn) Based on Products

  • Reagents & Consumables
  • Software & Systems
  • Services

Global Genome Editing/Genome Engineering Market Revenue (US$ Mn) Based on Application

  • Animal Genetic Engineering
  • Plant Genetic Engineering
  • Diagnostic Applications
  • Drug Discovery & Development
  • Other

Global Genome Editing/Genome Engineering Market Revenue (US$ Mn) Based on End Users

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic & Government Research Institutes

Global Genome Editing/Genome Engineering Market Revenue (US$ Mn) Based on Region

Europe Genome Editing/Genome Engineering Market Revenue (US$ Mn) by Country

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

North America Genome Editing/Genome Engineering Market Revenue (US$ Mn) by Country

  • U.S.
  • Canada

Asia Pacific Genome Editing/Genome Engineering Market Revenue (US$ Mn) by Country

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Genome Editing/Genome Engineering Market Revenue (US$ Mn) by Country

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa Genome Editing/Genome Engineering Market Revenue (US$ Mn) by Country

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Our Clients

Media Citations

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
$3786
$10000
$10000
Related Reports
Get a Custom Report
Contact us with a specific research request.

Kindly share us with a topic or product segment or objectives to meet your strategy goals
Review Request

We’ll review your request & send a personalized quote for cost and time needed
Final Delivery

Sit back while our team work on your research. We will send bi-monthly updates and discuss our finding on a conference call upon final delivery..

Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.

Category
Quick Links
Office Address